TRAN, H.; VO, T.; NGUYEN, M. N. High expression of DIMT1 correlates with poor prognosis and high risk of bone metastasis in breast cancer patients. Science and Technology Development Journal: Health Sciences, v. 1, n. 2, p. 52-63, 8 fev. 2021.